解整合素金属蛋白酶28(ADAM28)重组蛋白
Recombinant A Disintegrin And Metalloprotease 28 (ADAM28)
ADAM23; MDCL; eMDCII; Metalloproteinase-like, disintegrin-like, and cysteine-rich protein L; Epididymal metalloproteinase-like, disintegrin-like, and cysteine-rich protein II
- 编号RPK202Hu01
- 物种Homo sapiens (Human，人) 相同的名称，不同的物种。
- 来源原核表达
- 宿主E.coli
- 内毒素水平<1.0EU/µg(LAL法测定)
- 亚细胞定位细胞膜
- 预测分子量29.3kDa
- 实际分子量34kDa(差异分析请参阅说明书)
- 片段与标签Glu525~Lys774 with N-terminal His Tag
- 缓冲液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性状冻干粉
- 纯度> 97%
- 等电点7.5
-
应用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，请参见活性蛋白。 - 下载 英文说明书 中文说明书
- 规格 10µg50µg 200µg 1mg 5mg
- 价格 ¥ 1032 ¥ 2580 ¥ 5160 ¥ 15480 ¥ 38700
- 欲了解实际交易价格和更多情况，请与当地经销商联系!
-
产品包装(模拟)
-
产品包装(模拟)
-
Figure . Gene Sequencing (extract)
-
Figure. SDS-PAGE
-
通过ISO 9001、ISO 13485质量体系认证
序列
用法
Reconstitute in ddH2O to a concentration of 0.1-0.25 mg/mL. Do not vortex.
储存
避免反复冻融。2-8°C不超过一个月，-80°C不超过12个月。
稳定性
热稳定性以损失率显示。损失率是由加速降解试验决定，具体方法如下：在37°C孵育48小时，没有显著的降解或者沉淀产生。保质期内，在适当的条件下存储，损失率低于5%。
增值服务
相关产品
| 编号 | 适用物种：Homo sapiens (Human，人) | 应用(仅供研究使用，不用于临床诊断！) |
| RPK202Hu01 | 解整合素金属蛋白酶28(ADAM28)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAK202Hu01 | 解整合素金属蛋白酶28(ADAM28)多克隆抗体 | WB; IHC; ICC; IP. |
| MAK202Hu21 | 解整合素金属蛋白酶28(ADAM28)单克隆抗体 | WB; IHC; ICC; IP. |
| SEK202Hu | 解整合素金属蛋白酶28(ADAM28)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMK202Hu | 解整合素金属蛋白酶28(ADAM28)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
参考文献
| 杂志 | 参考文献 |
| Rapid Communications in Mass Spectrometry | Urinary protein profiling by liquid chromatography/tandem mass spectrometry: ADAM28 is overexpressed in bladder transitional cell carcinoma [Pubmed: 21913264] |
| Medical Oncology | Baseline and decline of serum ADAM28 during chemotherapy of advanced non-small cell lung cancer: a probable predictive and prognostic factor [SpringerLink: kg628446760r60rl] |
| Immunology & Cell Biology | ADAM28 is elevated in humans with the metabolic syndrome and is a novel sheddase of human tumour necrosis factor-α. [PubMed: 23010875] |
| Leuk Res | ADAM28 overexpression regulated via the PI3K/Akt pathway is associated with relapse in [PubMed: 26340916] |
| Disease Markers | Adamalysines as Biomarkers and a Potential Target of Therapy in Colorectal Cancer Patients: Preliminary Results [Pubmed: 31565100] |
留言咨询